Selexipag in patients with complex or uncorrected congenital heart disease: Single centre experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selexipag in patients with complex or uncorrected congenital heart disease: Single centre experience

Published:2022-06 Issue: Volume:8 Page:100353
ISSN:2666-6685
Container-title:International Journal of Cardiology Congenital Heart Disease
language:en
Short-container-title:International Journal of Cardiology Congenital Heart Disease

Author:

Meras Pablo^ORCID,Merino Carlos,Gonzalez-Garcia Ana Elvira,Ruiz-Cantador Jose

Funder

Johnson and Johnson

Publisher

Elsevier BV

Subject

General Medicine

Reference7 articles.

1. Survival in primary pulmonary hypertension: the impact of epoprostenol therapy;McLaughlin;Circulation,2002

2. Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study;Beghetti;Eur J Heart Fail,2019

3. Selexipag in congenital heart disease-associated pulmonary arterial hypertension and Eisenmenger syndrome: first report;El-Kersh;Am J Therapeut,2018

4. Use of the prostacyclin receptor agonist selexipag in patients with pulmonary arterial hypertension associated with eisenmenger syndrome;Demerouti;Can J Cardiol,2021

5. Contemporary use of Selexipag in pulmonary arterial hypertension associated with congenital heart disease: a case series;Blissett;Eur Heart J Case Rep,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease;Heart;2023-10-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP